AXLA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 2.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Axcella Health Insider Trading History Chart

Axcella Health Share Price & Price History

^$0.40

▼ -0.0391 (-8.89%)

As of 12/29/2023 04:59 PM ET

Axcella Health Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/1/2023	Margaret Koziel	Insider	Sell	27	$14.50	$391.50	995
10/19/2022	William Hinshaw	CEO	Sell	640	$39.00	$24,960.00	3,280
10/13/2022	Des Produits Nestle S Societe	Major Shareholder	Buy	146,341	$41.00	$5,999,981.00	444,217
9/6/2022	Margaret Koziel	Insider	Sell	21	$63.00	$1,323.00	1,022
6/1/2022	Margaret Koziel	Insider	Sell	23	$50.25	$1,155.75	1,044

SEC Filings (Institutional Ownership Changes) for Axcella Health (NASDAQ:AXLA)

65.07% of Axcella Health stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Axcella Health Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/14/2023	Schonfeld Strategic Advisors LLC	100,600	$1.05M	0.0%	N/A	3.412%
5/1/2023	Virtu Financial LLC	83,456	$40K	0.0%	N/A	0.113%
2/14/2023	Flagship Pioneering Inc.	29,251,545	$9.36M	0.3%	+55.0%	39.766%
7/15/2022	Pinnacle Private Wealth LLC	61,500	$0.13M	0.0%	+108.5%	0.117%
5/26/2022	HarbourVest Partners LLC	4,378,661	$11.25M	2.3%	+55.9%	8.328%
5/17/2022	Flagship Pioneering Inc.	18,867,785	$48.49M	1.1%	+50.4%	35.884%
5/11/2022	Edgewood Management LLC	100,000	$0.26M	0.0%	+33.3%	0.190%
5/3/2022	Cutter & CO Brokerage Inc.	19,800	$51K	0.0%	-24.7%	0.038%
4/29/2022	Pinnacle Private Wealth LLC	29,500	$76K	0.0%	+43.9%	0.056%
2/10/2022	Cutter & CO Brokerage Inc.	26,300	$55K	0.0%	-25.5%	0.068%
2/7/2022	Pinnacle Private Wealth LLC	20,500	$43K	0.0%	N/A	0.053%
11/15/2021	Marshall Wace LLP	40,017	$0.12M	0.0%	-44.7%	0.105%
8/25/2021	Marshall Wace LLP	72,422	$0.29M	0.0%	+31.4%	0.190%
8/17/2021	Bridgeway Capital Management LLC	137,967	$0.55M	0.0%	-15.1%	0.361%
8/16/2021	Charles Schwab Investment Management Inc.	10,305	$42K	0.0%	-66.9%	0.027%
8/16/2021	State Street Corp	70,676	$0.28M	0.0%	-68.5%	0.185%
8/16/2021	Marshall Wace LLP	72,422	$0.29M	0.0%	+31.4%	0.190%
8/13/2021	Renaissance Technologies LLC	158,202	$0.63M	0.0%	+129.0%	0.414%
8/13/2021	Northern Trust Corp	35,158	$0.14M	0.0%	-79.9%	0.092%
8/13/2021	Geode Capital Management LLC	136,883	$0.55M	0.0%	-40.7%	0.359%
8/13/2021	Vanguard Group Inc.	909,389	$3.65M	0.0%	-7.7%	2.382%
8/13/2021	FMR LLC	5,658,365	$22.69M	0.0%	+0.1%	14.821%
8/12/2021	Edgewood Management LLC	25,000	$100K	0.0%	N/A	0.065%
8/12/2021	Dimensional Fund Advisors LP	117,443	$0.47M	0.0%	-5.5%	0.308%
8/12/2021	Ergoteles LLC	64,015	$0.26M	0.0%	N/A	0.168%
8/11/2021	Bank of New York Mellon Corp	43,572	$0.18M	0.0%	-49.2%	0.114%
8/9/2021	Cutter & CO Brokerage Inc.	35,300	$0.14M	0.0%	N/A	0.092%
5/17/2021	Nuveen Asset Management LLC	64,749	$0.31M	0.0%	-10.4%	0.172%
5/14/2021	Dimensional Fund Advisors LP	124,286	$0.59M	0.0%	+51.8%	0.329%
5/13/2021	Barclays PLC	12,944	$62K	0.0%	+159.0%	0.034%
5/13/2021	Renaissance Technologies LLC	69,087	$0.33M	0.0%	+17.5%	0.183%
5/12/2021	Northern Trust Corp	174,517	$0.83M	0.0%	-8.1%	0.463%
5/12/2021	Geode Capital Management LLC	230,685	$1.10M	0.0%	+4.4%	0.612%
5/12/2021	JPMorgan Chase & Co.	29,990	$0.14M	0.0%	+311.1%	0.080%
5/12/2021	UBS Group AG	7,720	$37K	0.0%	+161.8%	0.020%
5/11/2021	Acadian Asset Management LLC	67,736	$0.32M	0.0%	-19.3%	0.180%
5/7/2021	BlackRock Inc.	1,040,976	$4.96M	0.0%	+2.1%	2.762%
3/8/2021	Dimensional Fund Advisors LP	81,873	$0.43M	0.0%	+28.3%	0.218%
2/25/2021	Dimensional Fund Advisors LP	81,873	$0.43M	0.0%	+28.3%	0.218%
2/24/2021	Virtu Financial LLC	15,682	$81K	0.0%	N/A	0.042%
2/19/2021	JPMorgan Chase & Co.	7,295	$37K	0.0%	-47.5%	0.019%
2/16/2021	Squarepoint Ops LLC	24,397	$0.13M	0.0%	-66.8%	0.065%
2/11/2021	Northern Trust Corp	189,806	$0.99M	0.0%	+9.7%	0.506%
2/11/2021	Barclays PLC	4,998	$26K	0.0%	-26.7%	0.013%
2/10/2021	Rhumbline Advisers	10,150	$53K	0.0%	N/A	0.027%
2/10/2021	Renaissance Technologies LLC	58,800	$0.31M	0.0%	+4.3%	0.157%
2/9/2021	Wells Fargo & Company MN	20,507	$0.11M	0.0%	+24.6%	0.055%
2/9/2021	Bank of New York Mellon Corp	87,116	$0.45M	0.0%	+148.8%	0.232%

Data available starting January 2016

See Full Table

Axcella Health Inc. operates as a clinical-stage biotechnology company in the United States. The company treats complex diseases using endogenous metabolic modulators. Its product pipeline includes AXA1125 that is in Phase 2a clinical trial for long COVID therapy for patients, as well as Phase 2b clinical trial for treating non-alcoholic steatohepatitis; and AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.

Today's Range

Now: $0.40

$0.36

$0.51

50 Day Range

MA: $0.84

$0.40

$4.58

52 Week Range

Now: $0.40

$0.34

$41.25

Volume

6,700 shs

Average Volume

267,009 shs

Market Capitalization

$1.18 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.46